Dr. Reddys Laboratories informs about updates

23 Mar 2019 Evaluate

Further to the intimation dated February 19, 2018 regarding US Securities Class Action Lawsuit, Dr. Reddys Laboratories has informed that on March 21, 2019 the United States District Court for the District of New Jersey issued its decision (dated March 20, 2019) granting in part and denying in part its Motion to Dismiss. The Court has dismissed Plaintiff's claims with respect to 17 out of the 22 alleged misstatements. As intimated earlier, the Company believes that the remaining alleged claims of misstatements are without merit and intends to vigorously defend itself against them.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1271.40 20.30 (1.62%)
11-Dec-2025 14:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1802.00
Dr. Reddys Lab 1271.40
Cipla 1509.65
Zydus Lifesciences 924.80
Lupin 2082.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×